Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie-Christin Demes

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
Pathology Oncology Research : POR|April 12, 2024
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric settingJörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, et al.
Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2024
Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutationsAnna Kron, Matthias Scheffler, Marcel Wiesweg, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
The Journal of Molecular Diagnostics : JMD|June 19, 2022
Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung CancerThomas Depoilly, Simon Garinet, Léon C van Kempen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
Pathology Oncology Research : POR|April 12, 2024
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric settingJörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, et al.
Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2024
Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutationsAnna Kron, Matthias Scheffler, Marcel Wiesweg, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
The Journal of Molecular Diagnostics : JMD|June 19, 2022
Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung CancerThomas Depoilly, Simon Garinet, Léon C van Kempen, et al.
Pageof 1